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Abstract Aging is linked to loss of the self-renewal
capacity of adult stem cells. Here, we observed that human
multipotent stem cells (MSCs) underwent cellular senes-
cence in vitro. Decreased expression of histone deacetylases
(HDACs), followed by downregulation of polycomb group
genes (PcGs), such as BMI1, EZH2 and SUZ12, and by
upregulation of jumonji domain containing 3 (JMJD3), was
observed in senescent MSCs. Similarly, HDAC inhibitors
induced cellular senescence through downregulation of
PcGs and upregulation of JMJD3. Regulation of PcGs was
associated with HDAC inhibitor-induced hypophosphory-
lation of RB, which causes RB to bind to and decrease the
transcriptionalactivityofE2F.JMJD3expressionregulation
was dependant on histone acetylation status at its promoter
regions. A histone acetyltransferase (HAT) inhibitor pre-
vented replicative senescence of MSCs. These results
suggest that HDAC activity might be important for MSC
self-renewal by balancing PcGs and JMJD3 expression,
which govern cellular senescence by p16
INK4A regulation.
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Introduction
Modiﬁcation of chromatin by epigenetic regulatory mecha-
nisms, including acetylation, deacetylation and methylation
of histones, is considered an important mechanism for stem
cell pluripotency [1]. Nuclear transplantation remodels epi-
genetic marks to reprogram somatic cell by balancing
between heterochromatic and euchromatic marks [2].
Transduction of exogenous ‘‘pluripotency genes,’’ such as
OCT4 and SOX2, to somatic cells to induce pluripotency
showed that epigenetic modulations for endogenous stem-
ness genes rebound, and silence of exogenes are necessary
for full reprogramming [3, 4]. Pan et al. [5] reported that
localizationoftrimethylationofhistonH3atlysine4residue
(H3K4Me3), an euchromatic mark of histone, is predomi-
nant in OCT4, SOX2 and NANOG genes in embryonic stem
cells, and colocalization of both H3K4Me3 and trimethyla-
tionofhistoneH3atlysine27residue(H3K27Me3)occurred
during differentiation to repress these pluripotency genes.
Takentogether,thechromatinstatusofpluripotencygenesis
crucial for regulation of self-renewal and pluripotency of
stem cells.
Aging of an organism is a complex process that involves
the decline of multiple systems that are required to
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the impairment of tissue maintenance and repair [6].
Recent studies suggest that an age-associated decline in
adult stem cell function might also be associated with these
processes [7–14].
Replicative senescence of multipotent stem cells (MSCs)
involves the ‘‘Hayﬂick phenomenon’’ [15], which is char-
acterized by cell enlargement, changes in morphology and
ultimate cessation of proliferation. Several lines of evidence
show that the polycomb group genes (PcGs) and JMJD3
histone lysine demethylase are involved in the homeostasis
of p16
INK4A, a key regulator of premature cellular senes-
cence. Polycomb repressor complex 2 (PRC2) initiates
chromatin repression by binding to target genes and induc-
ing methylation of histone proteins, primarily at lysine 27 of
histone H3, by EZH2, a protein with histone methyltrans-
ferase activity. Thereafter, members of polycomb repressor
complex 1 (PRC1), such as chromobox gene (CBX) and
BMI1, are able to recognize trimethylated histone H3 lysine
27 (H3K27Me3) and bind to condensed nucleosomes [16].
Young cells have compacted chromosomes at the CDKN2
(p16
INK4A–p19
ARF) locus as a result of a high extent of
H3K27Me3, which is caused by PcG interaction. On the
other hand, replicative senescence hinders binding of PRC2
group proteins to the CDKN2 locus, thereby reducing the
recruitment of the PRC1 maintenance complex to the
p16
INK4A promoter region. The collapse of polycomb pro-
tein complexes results in an increase of p16
INK4A
expression, which induces senescence [16, 17]. On the other
hand, JMJD3 increases in oncogene- and stress-induced
senescencetodemethylateH3K27Me3attheCDKN2locus,
leading to an increase of p16
INK4A expression [18]. Modi-
ﬁcation of histones bound to lineage-speciﬁcation genes is
also a critical step for maintenance of multipotency [19]. In
human adipose tissue-derived MSCs, H3K27Me3 and
H3K4Me3 bivalent modiﬁcations repress adipogenic genes
such as fatty acid-binding protein 4 (FABP4) and peroxi-
some proliferator activated receptor-c2 (PPARc2) by
coexisting on their promoter region of adipogenic genes and
repress the expression. Upon induction of adipogenesis,
histone H3 bound to the promoters of adipogenic genes is
acetylated at lysine 9 residues and is demethylated at lysine
27, activating transcription of adipogenic speciﬁc genes.
In contrast to its subordinate circuitry, the up-stream
regulatory mechanism of PcGs is poorly understood. BMI1
possesses a c-MYC binding E-box motif in its proximal
promoter, and its transcription has been demonstrated to be
regulated by c-MYC [20]. EZH2, EED and SUZ12,
members of the PRC2 complex, are induced by E2F
overexpression in the U2OS human osteosarcoma cell line
[21]. Indeed, the proximal promoters of EED and EZH2 are
bound by the E2F transcription factor and are transcrip-
tionally regulated by the RB-E2F interaction [22]. E2F
target genes are known to be stably repressed by the RB
tumor suppressor in senescent cells, but not in quiescent
cells [23].
Taken together, key mechanisms in the regulation of the
balance of PcGs and JMJD3 during replicative senescence,
which may be crucial for maintenance of self-renewal in
adult stem cells, remain unclear. Here, we examined the
role of HDAC activity in PcGs and JMJD3 regulation to
keep MSCs from undergoing cellular senescence.
Materials and methods
Isolation and culture of hMSCs
Human adipose tissue-derived MSCs (hAD-MSCs) [23]
and human umbilical cord blood-derived MSCs (hUCB-
MSCs) [24] were isolated and cultured as previously
described. In brief, two clones of hAD-MSCs were estab-
lished from freshly excised mammary fat tissue from
Ba-Ram Plastic Surgery Hospital. Tissues were obtained
from 20- to 30-year-old women during reduction mam-
moplasty with informed consent. The hAD-MSCs were
maintained in K-NAC medium supplemented with 2 mM
N-acetyl-L-cysteine (Sigma-Aldrich, St. Louis, MO) and
L-ascorbic acid (0.2 mM, Sigma-Aldrich).
hUCB-MSCs were obtained from umbilical cord blood
immediately after full-term delivery with consent from
20–30-year-old mothers and approval of the Boramae
Hospital Institutional Review Board (IRB). Two hUCB-
MSC clones were used in this experiment. hUCB-MSCs
were maintained in DMEM (Invitrogen, Carlsbad, CA)
containing 10% FBS. All procedures for preparation and
utilization of hAD-MSCs (IRB no. 0611/001-001) and
hUCB-MSCs (IRB no. 0603/001-002) for research pur-
poses were approved by the institutional review board of
Seoul National University.
Measurement of proliferation potential
The effects of VPA and NaBu on MSC proliferation were
measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO)
assay, as described previously [25]. In brief, cells were
plated on 24-well plates at a density of 2.5 9 10
4/ml and
cultured for 24 h. At the end of the incubation, 50 llo f
MTT stock solution (5 mg/ml) was added, and the plates
were further incubated for 4 h at 37C. Formazan crystals
were solublized with DMSO, and the absorbance was
measured with an EL800 microplate reader (Bio Tek
Instruments, Winooski, VT). Cell population doubling
levels (CPDL) were also measured from passage 1 to pas-
sage 15. MSCs were seeded at a density of 4 9 10
5 cells
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performed at least three times, and the average values were
used for the CPDL graph.
Senescence-associated beta-galactosidase staining
Senescence-associated beta-galactosidase (SA b-gal) stain-
ing was performed as described by Narita et al. [26] with
modiﬁcations. MSCs were seeded on six-well plates at a
density of 1 9 10
5 cells/well for late passage cells and
5 9 10
4 cells/well for early passage cells. Cells were incu-
bated for 3 days until reaching appropriate conﬂuency. For
long-term HDAC inhibitor treatment, early passage cells
were seeded at adensityof 1–2 9 10
4 cells/well and treated
for 1, 3, 5 or 7 days. Cells were washed twice with PBS and
ﬁxed with 0.5% glutaraldehyde in PBS (pH 7.2) for 5 min at
room temperature. Cells were then washed with MgCl2-
containing PBS (pH 7.2, 1 mM MgCl2) and stained in X-gal
solution overnight at 37C. Cells were washed twice
with PBS, and the nuclei were stained with Hoechst 33258
(1 lg/ml; 10 min).
Immunocytochemistry
Immunocytochemical analyses of HDAC1, HDAC2,
c-MYC, BMI1, SUZ12, p16
INK4A, E2F-1 and RB were
performed. Cells cultured with or without 10 mM VPA or
5 mM NaBu for 5 or 7 days were ﬁxed in 4% parafor-
maldehyde and permeabilized with 0.2% Triton X-100
(Sigma-Aldrich, St Louis, MO). The cells were incubated
with 10% normal goat serum (Zymed Laboratories Inc.,
San Francisco, CA) and then stained with antibodies
against HDAC1 (1:200, Upstate Biotechnology, Lake
Placid, NY), HDAC2 (1:200, Upstate Biotechnology),
c-MYC (1:100, Santa Cruz, Santa Cruz, CA), BMI1 (1:200,
Abcam, Cambridge, UK), SUZ12 (1:200, Abcam) and
p16
INK4A (1:200, Abcam), E2F-1 (1:200, Santa Cruz) and
RB (Millipore, Billerica, MA) followed by 1 h incubation
with Alexa 488- or Alexa 594-labeled secondary antibody
(1:1,000; Molecular Probes, Eugene, OR). The nuclei were
stained with Hoechst 33258 (1 lg/ml; 10 min). The images
were captured with a confocal microscope (Nikon, Eclipse
TE200, Japan).
Western blot analysis
Western blot analyses of HDAC1, HDAC2, c-MYC,
JMJD3, BMI1, SUZ12, EZH2, p16
INK4A, H3K4Me3,
H3K27Me3 and RB were performed as described previ-
ously [25]. MSCs cultured with or without HDAC
inhibitors for 1, 3, 5 or 7 days were lysed with 50 mM
Tris–HCl buffer containing 0.1% Triton X100 freshly
supplemented with protease/phosphatase inhibitor cocktail
(1 mM phenylmethylsulfonyl ﬂuoride, 1 mM aprotinin,
1 mM leupeptin, 1 mM antipain and 0.1 mM sodium
orthovanadate). Protein samples were separated on 7.5–
15% SDS-PAGE and then transferred to nitrocellulose
membranes at 50 V, 350 mA for 5 h. All antibodies were
used according to the manufacturer’s instructions. Anti-
bodies used for Western blot analysis were HDAC1
(1:1,000, Upstate Biotechnology), HDAC2 (1:200, Upstate
Biotechnology), c-MYC (1:100, R&D Systems, Minneap-
olis, MN), JMJD3 (1:500, Santa Cruz), BMI1 (1:200,
Chemicon, Temecula, CA), SUZ12 (1:200, Abcam), EZH2
(1:200, Millipore), p16
INK4A (1:200, Abcam), H3K4Me3
(1:2,500, Abcam), H3K27Me3 (1:2,500, Upstate Biotech-
nology) and RB (1:1,000, Millipore). Protein bands were
detected using an enhanced chemiluminescence detection
kit (Amersham Pharmacia Biotech, Buckinghamshire, UK)
and X-ray ﬁlm after recognition with the respective sec-
ondary antibodies conjugated with horseradish peroxidase.
RT-PCR
Total cellular RNA was extracted from cells with TRIzol
reagent
TM (Invitrogen) according to the manufacturer’s
instructions. cDNA was synthesized by adding the puriﬁed
RNA and oligo-dT primers to Accupower RT premix
(Bioneer, Korea) according to the manufacturer’s instruc-
tions. PCR was conducted with Accupower PCR premix
(Bioneer). The primer sets used for this study are listed in
Table S1. All PCR products were analyzed by gel elec-
trophoresis on 1.5% agarose gels with ethidium bromide
staining, followed by ﬂuorescence digitization using a
Bio-Rad GelDoc XR system (Bio-Rad). Semi-quantitative
RT-PCR was conducted by quantifying RT-PCR band
using ImageJ image analysis software (National Institutes
of Health, USA). Each gene was normalized with beta-
actin or RPL13A as housekeeping control. At least three
independent analyses were done for each gene.
siRNA inhibition study
For speciﬁc HDAC1 and HDAC2 inhibition, siRNA inhi-
bition studies were performed using commercial siRNA
targeting HDAC1 and HDAC2 along with a non-targeting
siRNA (Dharmacon, ON Target plus SMART pool, cat.
nos. L-003493-00, L-003495-00, D-001210-01-05). siRNA
transfections were done according to manufacturer’s
instructions. In brief, cells were seeded at a density of
5 9 10
4 cells/well, and siRNA-containing media (without
addition of antibiotics) was added when cells reached 50%
conﬂuence. Cells were incubated with 50 or 100 nM
siRNA for 48 or 96 h. To investigate the long-term effect
of HDAC inhibition, cells were subcultured 48 h post-
siRNA transfection. Subcultured cells were stabilized for
HDAC regulates PcGs and JMJD3 116724 h and incubated with siRNA for 72 h at the same
concentration. After inhibition, RNA, protein extraction or
SA b-gal staining was performed for genetic or charac-
teristic analyses.
Chromatin immunoprecipitation assays
hAD-MSC and hUCB-MSC were seeded in 10-cm plates
at a density of 0.8–1 9 10
5 and cultured with or without
4 mM VPA or 2 mM NaBu for 7 days. Cells in late
passage were seeded at a density of approximately
5 9 10
5 cells per 10-cm plate and incubated for 7 days.
ChIP assays were performed according to the manufac-
turer’s protocol (ChIP assay kit, Upstate Biotechnology).
Chromatin was immunoprecipitated by antibodies accor-
ding to the manufacturer’s instructions. PCR reactions
were performed in a ﬁnal template dilution of 1:50, and
PCR products were analyzed by gel electrophoresis on
1.5–2% agarose gels with ethidium bromide staining,
followed by ﬂuorescence digitization using a Bio-Rad
GelDoc XR system (Bio-Rad). Semi-quantitative RT-PCR
was conducted by quantifying RT-PCR bands using
ImageJ image analysis software (National Institutes of
Health, USA). Each value was expressed as a ratio of
input value. The primer sets used for ChIP assays are
listed in Table S2.
Statistical analysis
All experiments were conducted at least in triplicate
(n = 3), and the results are expressed as the mean ± SD.
Statistical analysis was conducted via analysis of variance
(ANOVA), followed by Duncan’s multiple range tests or
Student’s t test. A value of p\0.05 was considered
signiﬁcant.
Results
Replicative senescence in hUCB- and hAD-MSCs
downregulates HDAC, c-MYC and PcGs
In order to induce replicative senescence, we repeatedly
subcultured hUCB- and hAD-MSCs in vitro. Based on
the cumulative population doubling level, it was assumed
that human MSCs began to lose their proliferation
potential at around the tenth passage (Figure S1). At
the 19th passage, we conﬁrmed that both hUCB- and
hAD-MSCs completely lost their self-renewal capability,
as evidenced by a substantial decrease of proliferation
potential and the development of senescent phenotypes,
which were revealed using senescence-associated beta-
galactosidase (SA b-gal) staining (Fig. 1a). The senes-
cence status of MSCs was divided into three grades
based on passage numbers: early (fewer than 10 pas-
sages), intermediate (10 to 15 passages) and late (more
than 16 passages). It was observed that senescent hUCB-
and hAD-MSCs had reduced proliferative potential (less
than 50% of early passage MSCs), as shown by the
MTT cell proliferation assay (Fig. 1b). We speculated
that the expression levels of HDAC1 and HDAC2, rep-
resentative HDACs in eukaryotes, and c-MYC would
decrease, based on our previous report indicating that
HDAC activity is crucial for maintaining proliferative
potential and the multi-lineage differentiation ability of
MSCs in vitro. Indeed, mRNA and protein expression
levels of HDAC1, HDAC2 and c-MYC were downreg-
ulated upon replicative senescence of MSCs (Fig. 1c;
Figure S1A). In addition, in vitro cellular senescence
altered the localization of these proteins from nuclear to
cytosolic (Figure S1C).
We observed that mRNA and protein expression levels
of PcGs, such as BMI1, SUZ12 and EZH2, and JMJD3
histone lysine demethylase decreased in senescent hUCB-
and hAD-MSCs. As a result, p16
INK4A expression was
increased in senescent MSCs. In contrast, the expression
level of EED was not affected during senescence of MSCs,
as shown by RT-PCR and immunoblot analyses (Fig. 1e, f;
Figure S1B). In order to conﬁrm whether the upregulation
of p16
INK4A depends on demethylation at lysine 27 of
histone H3 (H3K27), we performed a ChIP assay and
compared H3K27 to anti-trimethylated H3K4 (a repressive
histone marker known as a target site for EZH2 histone
methyltransferase) (Fig. 1g). It was observed that the pro-
moter region was enriched with trimethylated H3K27
(H3K27Me3), not with the activated histone marker,
H3K4Me3.
In order to conﬁrm the alteration of HDACs, c-MYC and
PcGs expression in vivo, we used an in vivo murine aging
model to analyze expression levels of these genes by
RT-PCR. Among several organs, liver and inguinal fat
showed a drastic decrease in HDAC, c-MYC and PcG
expression. In contrast, other organs, such as skin, did not
show a signiﬁcant difference between young and old mice.
As shown in Figure S4, expression of HDAC1 and HDAC2
in 16-month-old (old) B6 mouse livers and inguinal fat pads
were less than 50% of that of the 3-month-old (young) mice.
In old animals, PcG expression levels were 20–30% of
young animals, and expression levels of c-MYC in old
animal livers were reduced to 10% of those in young
animals. However, in the inguinal fat pad, the expression
level of c-MYC was maintained at 60% of the young animal
levels (Figure S4).
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causes MSC senescence
In a previous report, we observed that a 3-day treatment of
HDAC inhibitors, such as sodium butyrate (NaBu) and
valproic acid (VPA), induced p21
CIP1/WAF1 expression and
arrested MSCs in the G2/M phase of the cell cycle without
affecting p16
INK4A expression or cellular senescence [27].
It was suggested that abrupt expression of p21
CIP1/WAF1 by
high concentrations of HDAC inhibitors (10 and 5 mM for
VPA and NaBu, respectively) placed cells into a quiescent
stage before p16
INK4A proteins could accumulate and the
cells could senesce. In order to assess whether HDAC is
involved in cellular senescence of MSCs, we extended the
Fig. 1 Replicative senescence of hUCB- and hAD-MSCs. a MSCs
undergo replicative senescence upon repeated (more than 15
passages) subculture in vitro, as visualized by SA b-gal staining.
b MSCs begin to lose proliferation potential at around the tenth
passage (intermediate), and in senescent stage (late), proliferation
potential was reduced to 50% or less compared to early passage
(fewer than seven passages) MSCs. Expression levels of HDAC1,
HDAC2 and c-MYC are downregulated during repeated subculture-
induced senescence of MSCs as shown by RT-PCR (c) and
immunoblot analysis (d). Senescent MSCs show decreased expression
levels of BMI1 (PRC1 member), SUZ12 and EZH2 (members of
PRC2) and an increased expression level of JMJD3. p16
INK4A
expression levels also increased, as shown by RT-PCR (e) and
immunoblot analysis (f). g Chromatin immunoprecipitation was
performed to address whether upregulation of p16
INK4A depends on
demethylation of the H3K27 residue. Speciﬁc demethylation of
H3K27, not of H3K4, was observed in late passage (p18) hUCB-
MSCs. Two regions on the p16
INK4A promoter targeted by speciﬁc
primer sets are described schematically. Graphs represent semi-
quantiﬁcation of RT-PCR results from at least three independent
experiments. * and ** represent statistical signiﬁcance at the levels of
p\0.05 and p\0.005, respectively
HDAC regulates PcGs and JMJD3 1169treatment period up to 7 days, where we observed that
MSCs acquired a senescent phenotype based on SA b-gal
staining (Fig. 2a). HDAC1, HDAC2, c-MYC (both
total and phosphorylated form), BMI1 and SUZ12
showed similar cytosolic localization by HDAC inhibitor-
induced cellular senescence of MSCs, as shown by
immunocytochemistry (Fig. 2a; Figure S2). These obser-
vations suggest that inhibition of HDAC activity by
chemical inhibitors, VPA and NaBu, results in MSC cel-
lular senescence and, similar to replicative senescence of
MSCs, downregulation of c-MYC.
In order to further conﬁrm whether molecular mecha-
nisms of HDAC inhibitor-mediated cellular senescence are
similar to that of replicative senescence, we conducted
time-course RT-PCR (Figure S3) and immunoblot experi-
ments (Fig. 2b, c) for the aforementioned markers, such as
c-MYC, PcGs, JMJD3 and p16
INK4A. hUCB- and hAD-
MSCs showed decreased expression of c-MYC, BMI1 and
SUZ12. JMJD3 was upregulated by 1-day treatment of
HDAC inhibitors, and its expression level peaked at 3 days
of treatment. p16
INK4A was slightly increased from 3 days
of treatment of HDAC inhibitors. Interestingly, a decrease
of BMI1 protein expression was consistently followed by
c-MYC downregulation, suggesting that BMI1 might be
regulated by c-MYC. On the other hand, alteration of
EZH2, SUZ12 and JMJD3 expression levels were observed
immediately after VPA or NaBu treatment, indicating that
those genes may have distinct regulatory mechanisms from
that of BMI1. Upregulation of p16
INK4A expression fol-
lowed alteration of BMI1, EZH2, SUZ12 and JMJD3. To
further conﬁrm whether the alteration of EZH2 and JMJD3
expression level by HDAC inhibitor treatment causes his-
tone lysine methylation, we performed immunoblot using
anti-H3K27Me3 and anti-H3K4Me3 antibodies. Accord-
ingly, it was observed that the protein level of H3K27Me3,
not of H3K4Me3, was signiﬁcantly reduced by treatment
with 2 mM VPA or 1 mM NaBu, indicating that the
alteration of EZH2 and JMJD3 expression level affected
the balance between histone methyltransferase and
demethylase activity, especially on lysine 27 residue of
histone H3 (H3K27). Using ChIP, we further assessed
whether this global alteration of methylation pattern on
Fig. 2 The loss of HDAC activity is a crucial step in MSC
senescence. a HDAC inhibitors, VPA and NaBu, induce cellular
senescence in hUCB- and hAD-MSCs upon 7 days of treatment in
culture, as shown by SA b-gal staining. Localization of HDAC1,
HDAC2 and c-MYC proteins in HDAC inhibitor-treated MSCs were
visualized by immunocytochemistry. b, c Protein expression levels of
p16
INK4A, JMJD3, c-MYC, BMI1 and SUZ12 were assessed using
immunoblot analysis. Both hUCB- and hAD-MSCs were treated with
2 mM VPA or 1 mM NaBu for the indicated time periods. Twenty
micrograms of whole cell lysates were loaded, and immunoblot
analysis was performed as described in ‘‘Materials and methods.’’
d Time-course changes in global H3K27 and H3K4 methylation
levels were assessed using immunoblot analysis upon treatment of
HDAC inhibitors in hUCB-MSCs. e Cells were treated for 7 days,
and ChIP assay was performed to analyze histone methylation
patterns at the p16
INK4A promoter region. A decrease of H3K27Me3
enrichment, not of H3K4Me3, was observed in both VPA- and NaBu-
treated hUCB-MSCs. Two regions on p16
INK4A promoter targeted by
speciﬁc primer sets are described schematically
b
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promoter region of p16
INK4A. Indeed, the amount of
H3K27Me3, but not of H3K4Me3, at the proximal pro-
moter region of p16
INK4A was decreased by treatment of
HDAC inhibitors, again suggesting the speciﬁcity of EZH2
and JMJD3 on H3K27Me3 regulation (Fig. 2e). Taken
together, treatment of HDAC inhibitor alters PcGs and
JMJD3 expression levels, which are important for regula-
tion of p16
INK4A expression in young MSCs by erasing
the H3K27Me3 closed chromatin structure in a substrate-
speciﬁc manner.
Histone deacetylase activity is speciﬁc for regulation
of MSC senescence
To conﬁrm whether the regulation of PcGs and JMJD3,
which leads to upregulation of p16
INK4A, is speciﬁc to
HDAC activity, inhibition assays using short interference
RNAs that speciﬁcally targeted either HDAC1 or HDAC2
were conducted. Both siHDAC1 and siHDAC2 inhibited
c-MYC expression in hUCB- and hAD-MSCs to less than
50% of control groups (Fig. 3a, b). The expression levels
of PcGs, such as BMI1, EZH2 and SUZ12, were also
reduced by speciﬁc inhibition of HDACs using siRNA. On
the other hand, JMJD3 and p16
INK4A were upregulated by
siRNA-mediated inhibition of HDACs. To determine
whether the alteration of PcGs, JMJD3 and p16
INK4A
expression levels by siRNA-mediated speciﬁc inhibition of
HDAC1 or HDAC2 is enough to trigger cellular senes-
cence in MSCs, we performed SA b-gal staining of siRNA
transfectants. It was observed that siHDAC1 was more
efﬁcient in causing cellular senescence, as evidenced by
slightly elevated SA b-gal activity in siHDAC1-transfected
groups (Fig. 3c). Taken together, these data demonstrate
that HDAC activity is essential for PcG and JMJD3
expression levels and the repression of p16
INK4A, all of
which maintain the self-renewal capability of MSCs.
Regulatory mechanism of HDACs; RB
hypophosphorylation by HDAC inhibitors
causes downregulation of PcGs
To clarify how HDAC activity governs JMJD3 expression,
we performed ChIP for the JMJD3 proximal promoter
region using speciﬁc antibodies against acetylated histone
H3 (AcetylH3) and H4 (AcetylH4) in hUCB-MSCs.
Fig. 3 HDAC1 and HDAC2
inhibition regulates histone-
modulating genes. a, b Speciﬁc
targeting of HDAC1 and
HDAC2 by using siRNA
induced increased expression of
JMJD3 and repression of
c-MYC and polycomb genes, as
shown by RT-PCR analysis.
Graphs represent semi-
quantiﬁcation of RT-PCR
results from at least three
independent experiments.
c Speciﬁc downregulation of
HDAC1 and HDAC2 is enough
to cause cellular senescence in
MSCs. siHDAC1 caused an
increase in SA b-gal activity
Fig. 4 HDAC inhibitors regulate JMJD3 expression by histone H3
acetylation. After 12- or 24-h treatment of HDAC inhibitors on
hUCB-MSCs, ChIP assays were performed to investigate acetylation
of histone H3 and H4 on JMJD3 promoter regions. In the diagram,
four target regions on the promoter of JMJD3 that were investigated
using speciﬁc primer sets are described schematically
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enriched with AcetylH3 by treatment of HDAC inhibitors
for 12 or 24 h, indicating that HDAC activity is important
in JMJD3 expression because of chromatin modiﬁcation in
the JMJD3 promoter region.
In regard to PcGs, we looked into RB and E2F inter-
action. As reported, c-MYC has a binding site for the E2F
transcription factor in its P2 promoter region, and hence, it
is transcriptionally activated by E2F [28]. The retinoblas-
toma protein (RB) interacts with DNA-binding proteins
such as E2F to regulate transcriptional activity or to serve
as a binding dock for transcriptional silencers, such as
HDACs [29], HMTases [30] and DNA methyltransferases
(DNMTs), to suppress gene expression [31, 32]. The
phosphorylation status of the RB protein is important for
determining the activity of RB as a transcriptional repres-
sor. Hyperphosphorylation, induced by the cyclin-CDK
complex, for example, detaches RB from E2F, allowing
non-bound free E2F to have transcriptional activity [28,
33]. SUZ12 has an E2F binding site on its upstream
promoter and is regulated by E2F [34]. EZH2, however,
lacks E2F binding sequences, but is still regulated by E2F
transcriptional activity, as reported by Bracken et al. [22].
Several lines of evidence indicate that HDAC activity
correlates to RB phosphorylation status. Inhibition of
HDAC activity using a HDAC inhibitor, trapoxin, results in
hypophosphorylation of RB [35].
To assess whether RB phosphorylation status is modu-
lated during HDAC inhibitor-induced MSC senescence,
immunoblot analysis was performed. As shown in Fig. 5a,
hyperphosphorylated RB in control MSCs was signiﬁcantly
dephosphorylated by 12 h and more signiﬁcantly by 24 h
after treatment with VPA and NaBu. The signiﬁcant
dephosphorylation 24 h post-treatment occurred concomi-
tantly with the initiation of EZH2, SUZ12 and c-MYC
downregulation, as shown in Fig. 2b and c. Immunocyto-
chemical analysis showed that RB localization at the
nucleus was slightly increased by treatment of HDAC
inhibitors (Figure S5A). Moreover, HDAC inhibitor treat-
ment increased E2F bound to RB as shown by
immunoprecipitation (Figure S5B). ChIP analysis data
showed that the RB protein is enriched in c-MYC, EZH2
and SUZ12 promoter regions, suggesting that HDAC
inhibitor-mediated hypophosphorylated RB binds to the
E2F transcription factor and suppresses expression of target
genes, including EZH2, SUZ12 (Fig. 5b, c) and c-MYC
(Figure S6A).
Taken together, these data demonstrate that HDAC
regulates JMJD3 by affecting the histone acetylation
status of the JMJD3 promoter region. On the other hand,
c-MYC, EZH2 and SUZ12 expression regulated the
phosphorylation status of the RB protein upon treatment
of HDAC inhibitors. In turn, changes of JMJD3 and
PcGs expression levels during HDAC inhibitor-mediated
cellular senescence of MSCs decreased expression of
the repressive chromatin marker, H3K27Me3, on the
p16
INK4A promoter region, thereby causing an increase of
p16
INK4A expression.
Role of c-MYC in cellular senescence of MSCs
We have described that HDAC activity is indispensable
for MSCs to maintain their self-renewal capability by
keeping them in the stem cell compartment and pre-
venting them from acquiring a senescent phenotype. In
this context, expression levels of c-MYC and BMI1 were
diminished during replicative senescence of MSCs
(Fig. 1; Figure S1), and, indeed, c-MYC expression was
speciﬁcally regulated by HDAC-mediated modulation of
RB hypophosphorylation, as shown in Fig. 5a and Figure
S6A. To further assess the role of c-MYC in MSC
senescence, a chemical inhibitor of c-MYC, 10058-F4,
was used in hUBC- and hAD-MSCs. A decrease in cell
Fig. 5 HDAC inhibitors regulate c-MYC, EZH2 and SUZ12 by RB
hypophosphorylation. a HDAC inhibitors induced RB hypophosph-
orylation within 24 h as shown by immunoblot assay. b, c After 12 or
24 h treatment of HDAC inhibitors on hUCB-MSCs, ChIP assays
were performed to investigate binding of RB and HDAC1 protein on
EZH2 (b) and SUZ12 (c) promoter regions. In the diagram, two target
regions on the promoter of each gene investigated using speciﬁc
primer sets and E2F binding site are described schematically
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observed (Figure S6B). Moreover, treatment of cells with
10058-F4 increased SA b-gal activity, indicating that
c-MYC activity is a pivotal regulator of MSC senescence
(Figure S6C). Additionally, BMI1 expression was
decreased by 10058-F4 treatment in hUCB- and
hAD-MSCs in a time-dependent fashion (Figure S6D),
suggesting that inhibition of c-MYC activity precedes the
downregulation of BMI1 expression in MSC senescence.
Indeed, c-MYC activity is important in the self-renewal
capability of MSC.
Histone acetyltransferase inhibitor prevents MSCs
from replicative senescence by sustaining PcG
and repressing JMJD3 expression levels
The aforementioned results strongly suggest that HDAC
activity, via regulation of PcGs, is pivotal for maintenance
of self-renewal and prevention of senescence of MSCs. In
this context, HDAC activity might regulate chromatin
structure in the proximity of the JMJD3 promoter. In
addition, the phosphorylation status of RB might directly
regulate EZH2 and SUZ12, or indirectly affect BMI1
through c-MYC modulation. Since histone acetyltrans-
ferases (HAT) are counteractive to HDACs, we assessed
the effects of a chemical inhibitor of HATs, anacardic
acid (AA), on the replicative senescence of MSCs.
Treatment of cells with AA slowed regression of the
doubling level of hUCB-MSCs, and moreover, increased
the proliferation potential of hAD-MSCs, as shown by
cumulative population doubling levels (Fig. 6a, b). In
order to conﬁrm whether the molecular mechanisms of
MSC senescence that lead to loss of self-renewal potential
are reversed by the HAT inhibitor, we compared the
expression levels of HDAC, c-MYC, PcGs and p16
INK4A
in AA-treated and control MSCs that displayed the
same doubling level. Ten micromolar anacardic acid
effectively prevented the replicative senescence-mediated
downregulation of HDAC2, BMI1 and SUZ12 in both
hUCB- and hAD-MSCs. Additionally, HDAC1, c-MYC
and EZH2 expression levels were upregulated in hUCB-
MSCs treated with 10 lM AA compared to the control
group (Fig. 6c). However, upregulation of those genes in
hAD-MSCs treated with AA treatment was not observed,
presumably because cells in the control group did not fall
into a senescent stage, as shown in the CPDL curve
(Fig. 6a). The expression level of JMJD3 was down-
regulated by treatment of AA in both hUCB- and
hAD-MSCs. Likewise, p16
INK4A expression levels were
downregulated by AA treatment in hUCB-MSCs, but
not in hAD-MSCs, compared to control group cells.
These results suggest that inhibition of HAT activity
is counteractive to replicative senescence-mediated
inactivation of HDACs and that the HAT inhibitor, ana-
cardic acid, might extend the self-renewal potential of
MSCs.
Fig. 6 A histone acetyltransferase inhibitor, anacardic acid (AA),
prevented MSCs from replicative senescence. a Cumulative popula-
tion doubling level was measured. The doubling level of the AA-
treated group was higher than that of control group. b Anacardic acid
prevented replicative senescence by sustaining proliferation ability
and early state morphology. c RNA was extracted during CPDL
experiments. Gene expression levels of AA treated and non-treated
cells were compared at the same doubling level by RT-PCR and PCR.
d Semi-quantiﬁcation of PCR product was performed by Image J
analysis. Graph shows relative gene expression levels of AA-treated
cells compared with control cells
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Replicative senescence is considered the cellular counter-
part of in vivo aging [36, 37], which is accompanied by
gene expression changes that might be regulated by epi-
genetic mechanisms resulting in permanent arrest of cell
proliferation [15]. Bypassing replicative senescence is a
crucial step for maintenance of stem cell self-renewal [36,
37]. Loss of self-renewal leads to breakdown of cell and
tissue homeostasis and the impairment of tissue mainte-
nance and repair [6].
Self-renewal of a stem cell, which can be described as
resulting from asymmetrical cell division by which a stem
cell gives rise to an identical stem cell and a daughter cell
with less self-renewal capability than its mother, is pivotal
for the maintenance of stem cell clonality and functional-
ity. In contrast, symmetrical division occurs in culture
dishes where stem cell populations robustly increase. The
increase of cell number by symmetrical cell division
appears to cause cells to lose stemness and eventually leads
to cellular senescence. It has been speculated that the loss
of a somatic stem cell population, as well as its function-
ality, is involved in age-related diseases [38].
Here, we report that hUCB- and hAD-MSCs senesce
and lose their self-renewal capability as a result of repeti-
tive subculture in vitro, as demonstrated by elevated
p16
INK4A expression and SA b-gal activity. Our results
indicate that MSC senescence in vitro initiates at around
the 10th passage (i.e., 30 cumulative doublings), and cells
completely undergo cellular senescence at around passage
15, although differences exist depending on the sources and
donors. In this context, a novel role of HDACs in the
regulation of polycomb group genes (PcGs), such as BMI1,
EZH2 and SUZ12, was crucial to keep MSCs in the stem
cell compartment. In order to extend our observations to an
in vivo aging model, we adopted an aged mouse model and
assessed mRNA expression of cellular senescence genes by
RT-PCR within several solid organs, as well as bone
marrow. Among these, liver and inguinal fat showed
signiﬁcant regulation of target genes, such as HDACs,
c-MYC, BMI1 and SUZ12.
Our previous report suggests that HDACs play a pivotal
role in the proliferation and controlled differentiation of
MSCs. In brief, we reported that HDAC inhibitors reduce
proliferation potential of human MSCs by upregulating
p21
CIP1/WAF1, a cyclin-dependent kinase (CDK) inhibitor,
and diminish the differentiation efﬁciency of MSCs into
adipocytes, chondrocytes and neuronal cells. In contrast,
HDAC inhibitors increase the osteogenic differentiation
capability of MSCs. Results from the previous study also
show that p16
INK4A is not upregulated in the same condi-
tions that increase p21
CIP1/WAF, suggesting a profound
difference in the regulatory mechanisms of both CDK
inhibitors. Cells were placed into a quiescent stage by high
concentrations of HDAC inhibitors, which mediate abrupt
expression of p21
CIP1/WAF1 before p16
INK4A protein
can accumulate and cells acquire senescent phenotypes.
In addition, it is well known that the upregulation of
p21
CIP1/WAF1 is mediated by hyperacetylation of core his-
tones upon inhibition of HDAC activity [39]; on the other
hand, the regulatory mechanism of p16
INK4A involves
histone methyltransferase (HMTase) activity [17]. Given
these data, the roles of p21
CIP1/WAF1 and p16
INK4A are
likely to differ in terms of stem cell self-renewal. It has
been suggested that the upregulation of p21
CIP1/WAF1 is
transient and strongly effective on cell cycle progression,
but not cellular senescence. The transient cell cycle arrest
by p21
CIP1/WAF1 may be reversed when causative factors,
such as the HDAC inhibitors used in our previous study,
are removed. On the other hand, expression of p16
INK4A
shows an accumulative effect on cellular senescence,
which is not likely reversed by removal of initiation
factors.
As previously reported by Bracken et al. [17], p16
INK4A,
which is adjacent to p19
ARF at the CDKN2A locus, is
regulated by HMTase-induced methylation of H3 core
histones on lysine 27 (H3K27Me3; a marker for tran-
scriptional silencing). In young ﬁbroblasts, the promoter of
p16
INK4A is bound by members of the PRC2-initiating
complex, such as SUZ12, which in turn recruits EZH2, a
member of the PRC2 complex that has HMTase activity
and speciﬁcally trimethylates the H3K27 residue. The
PRC1 maintenance complex can recognize and bind to the
PRC2 complex, which stabilizes the complexes and per-
manently silences transcription. Either the downregulation
of PRC1 or PRC2 causes somatic cellular senescence.
More recently, JMJD3, a histone lysine demethylase, was
identiﬁed as a transcriptional activator of p16
INK4A by
demethylating H3K27Me3 residues at CDKN2A locus
[18]. Histone modiﬁcation by methylation of lysine resi-
dues is also involved in lineage-speciﬁc differentiation of
MSCs [19]. Noer et al. have reported that H3K27Me3 and
H3K4Me3 bivalent marks of histone repress adipogenic
genes in undifferentiated hAD-MSCs. Upon adipogenic
stimulation, histones bound to adipogenic gene promoters
develop permissive transcription by acetylating H3K9
residues and by demethylating H3K27 residues. Indeed,
histone modiﬁcation enzymes affect MSC self-renewal by
regulating senescence and differentiation capabilities.
Interestingly, as shown by Guney et al. [20], BMI1 has a
c-MYC binding E-box motif in its proximal promoter, and
hence it is transcriptionally regulated by c-MYC. In the
present report, we demonstrated that binding of c-MYC to
the BMI1 promoter region decreases during MSC senes-
cence. Additionally, when MSCs were exposed to an
inhibitor of c-MYC, 10058-F4, the expression level of
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gesting that c-MYC directly relates BMI1 regulation. Since
the protooncogene c-MYC has an E2F-binding motif in its
P2 promoter, it is possible to speculate that BMI1 is indi-
rectly regulated by RB-E2F via c-MYC. In addition, the
PRC2 genes, EZH2 and SUZ12, are target genes of the E2F
transcriptional factor as shown in this report and by others
[22, 34], suggesting that there might be a common regu-
latory mechanism of PcGs. Hypophosphorylated RB binds
to and disrupts transcriptional activity of E2F, whereas
hyperphosphorylation of RB detaches RB from E2F, which
results in E2F target gene transcription [28, 33]. Therefore,
the phosphorylation status of the RB protein plays an
important intermediate role for the transcription of E2F
target genes, including PcGs. One of the most important
observations in this report is that the alteration of HDAC,
c-MYC, PcG and p16
INK4A genes by replicative senescence
was completely prevented by treatment of cells with a HAT
inhibitor, anacardic acid, during subculture in vitro. This
phenomenon showed that the loss of HDAC activity is a
crucial initiation step for MSC senescence and the failure
of self-renewal. As mentioned above, one of the biggest
shortcomings of adult stem cells is premature senescence,
which might limit the number of cells for transplantation.
To overcome premature senescence and enhance the usage
of MSCs, inhibition of HAT activity, which can be
achieved not by exogenous genetic modulation but by
relatively safe chemicals, might be a good strategy.
Taken together, the data in this report show that repli-
cative senescence and loss of MSC self-renewal involve
downregulation of HDACs, c-MYC and PcGs, which
eventually causes an accumulation of p16
INK4A expression
and an upregulation of SA b-gal activity as summarized in
Fig. 7. HDAC activity is crucial for the maintenance MSC
self-renewal because it regulates c-MYC expression, as
shown by experiments using HDAC chemical inhibitors
and speciﬁc siRNA constructs. A novel role of HDACs is
to regulate BMI1 indirectly by modulating the RB phos-
phorylation status and hence regulating binding to the E2F
binding site on the c-MYC P2 promoter. In turn, c-MYC
binds to the BMI1 promoter and regulates expression of
BMI1. The other essential role of HDACs is to regulate
expression of EZH2 and SUZ12, members of the PRC2
complex, directly through the RB-E2F pathway. E2F
directly binds to the promoter regions of EZH2 and SUZ12,
and therefore, hypophosphorylation of RB, mediated by
HDAC inhibition, represses their expression level. Conse-
quently, PcGs, including BMI1 and SUZ12, bind to the
p16
INK4A promoter and the trimethylated lysine 27 residue
on histone H3 to transcriptionally repress this gene. Inter-
estingly, the senescence-associated regulation of HDACs,
c-MYC, PcGs and p16
INK4A was completely reversed by
treatment of MSCs with a HAT inhibitor. In conclusion,
HDAC activity is pivotal for MSC self-renewal capability,
and development of methodologies for maintaining HDAC
activity during ex vivo expansion of MSCs while pre-
serving stem cell capacity should be pursued.
Acknowledgment This work was supported by the National
Research Foundation of Korea (NRF) grant funded by the Korea
Ministry of Education, Science and Technology (MEST no.
M10841000119-08N4100-11910).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB (2008)
Unraveling epigenetic regulation in embryonic stem cells. Cell
Stem Cell 2:123–134
2. Bian Y, Alberio R, Allegrucci C, Campbell KH, Johnson AD
(2009) Epigenetic marks in somatic chromatin are remodelled to
resemble pluripotent nuclei by amphibian oocyte extracts.
Epigenetics 4:194–202
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T,
Tomoda K, Yamanaka S (2007) Induction of pluripotent stem
cells from adult human ﬁbroblasts by deﬁned factors. Cell
131:861–872
4. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J,
Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R,
Slukvin II, Thomson JA (2007) Induced pluripotent stem cell
lines derived from human somatic cells. Science 318:1917–1920
Fig. 7 Schematic diagram of senescence regulation in young MSCs
and HDAC inhibitor-mediated senescent MSCs. a In young MSCs,
RB is hyperphosphorylated, and expression of EZH2, SUZ12 and
c-MYC is controlled by free E2F bound to their promoter region.
HDAC inhibitors dephosphorylate RB to bind to E2F transcription
factor to repress its transcriptional activity and silence EZH2, SUZ12
and c-MYC genes. Because c-MYC is an upstream regulator of
BMI1, HDAC inhibition results in BMI1 downregulation. b p16
INK4A
is repressed in young MSCs because of PcG-induced H3K27Me3
enrichment. Repression of PcG expression level and increase of
JMJD3 expression level caused by HDAC inhibition lead to
demethylation of H3K27 and p16
INK4A expression to senesce MSCs
HDAC regulates PcGs and JMJD3 11755. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA,
Stewart R, Thomson JA (2007) Whole-genome analysis of his-
tone H3 lysine 4 and lysine 27 methylation in human embryonic
stem cells. Cell Stem Cell 1:299–312
6. Zhao B, Benson EK, Qiao R, Wang X, Kim S, Manfredi JJ, Lee
SW, Aaronson SA (2009) Cellular senescence and organismal
ageing in the absence of p21
CIP1/WAF1 in ku80(-/-) mice.
EMBO Rep 10:71–78
7. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT,
Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scad-
den DT (2006) Stem-cell ageing modiﬁed by the cyclin-
dependent kinase inhibitor p16
INK4a. Nature 443:421–426
8. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R,
Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Increasing
p16
INK4a expression decreases forebrain progenitors and neuro-
genesis during ageing. Nature 443:448–452
9. Noda S, Horiguchi K, Ichikawa H, Miyoshi H (2008) Repopu-
lating activity of ex vivo-expanded murine hematopoietic stem
cells resides in the CD48-c-Kit?Sca-1?lineage marker-cell
population. Stem Cells 26:646–655
10. Meshorer E, Gruenbaum Y (2008) Gone with the Wnt/Notch:
stem cells in laminopathies, progeria, and aging. J Cell Biol
181:9–13
11. Rao MS, Mattson MP (2001) Stem cells and aging: expanding the
possibilities. Mech Ageing Dev 122:713–734
12. Scafﬁdi P, Misteli T (2008) Lamin A-dependent misregulation of
adult stem cells associated with accelerated ageing. Nat Cell Biol
10:452–459
13. Snyder EY, Loring JF (2005) A role for stem cell biology in the
physiological and pathological aspects of aging. J Am Geriatr Soc
53:S287–S291
14. Trosko JE (2008) Role of diet and nutrition on the alteration of
the quality and quantity of stem cells in human aging and the
diseases of aging. Curr Pharm Des 14:2707–2718
15. Hayﬂick L (1965) The limited in vitro lifetime of human diploid
cell strains. Exp Cell Res 37:614–636
16. Sparmann A, van Lohuizen M (2006) Polycomb silencers control
cell fate, development and cancer. Nat Rev Cancer 6:846–856
17. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D,
Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse
BT, Marine JC, Hansen KH, Helin K (2007) The polycomb group
proteins bind throughout the INK4A-ARF locus and are disas-
sociated in senescent cells. Genes Dev 21:525–530
18. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G,
Christensen J, Helin K (2009) The H3K27me3 demethylase
JMJD3 contributes to the activation of the INK4A-ARF locus in
response to oncogene- and stress-induced senescence. Genes Dev
23:1171–1176
19. Noer A, Lindeman LC, Collas P (2009) Histone H3 modiﬁcations
associated with differentiation and long-term culture of mesen-
chymal adipose stem cells. Stem Cells Dev 18:725–736
20. Guney I, Wu S, Sedivy JM (2006) Reduced c-Myc signaling
triggers telomere-independent senescence by regulating Bmi-1
and p16
INK4a. Proc Natl Acad Sci USA 103:3645–3650
21. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F,
Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K (2001) E2Fs
regulate the expression of genes involved in differentiation,
development, proliferation, and apoptosis. Genes Dev
15:267–285
22. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K
(2003) EZH2 is downstream of the pRB-E2F pathway, essential
for proliferation and ampliﬁed in cancer. EMBO J 22:5323–5335
23. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL,
Hannon GJ, Lowe SW (2003) Rb-mediated heterochromatin
formation and silencing of E2F target genes during cellular
senescence. Cell 113:703–716
24. Seo KW, Lee SR, Bhandari DR, Roh KH, Park SB, So AY, Jung
JW, Seo MS, Kang SK, Lee YS, Kang KS (2009) OCT4A con-
tributes to the stemness and multi-potency of human umbilical
cord blood-derived multipotent stem cells (hUCB-MSCs). Bio-
chem Biophys Res Commun 384:120–125
25. Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, Hwang
JW, Jung JY, Kim SH, Kang KS, Lee YS (2005) Ras/MAP kinase
pathways are involved in Ras speciﬁc apoptosis induced by
sodium butyrate. Cancer Lett 225:199–206
26. Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers
MP, Lowe SW (2006) A novel role for high-mobility group a
proteins in cellular senescence and heterochromatin formation.
Cell 126:503–514
27. Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW, Sun B,
Seo K, Lee YS, Kang SK, Jung JW, Kang KS (2009) Histone
deacetylase inhibitors decrease proliferation potential and multi-
lineage differentiation capability of human mesenchymal stem
cells. Cell Prolif 42:711–720
28. Ishida S, Shudo K, Takada S, Koike K (1995) A direct role of
transcription factor E2F in c-myc gene expression during gran-
ulocytic and macrophage-like differentiation of HL60 cells. Cell
Growth Differ 6:229–237
29. Ferreira R, Naguibneva I, Mathieu M, Ait-Si-Ali S, Robin P,
Pritchard LL, Harel-Bellan A (2001) Cell cycle-dependent
recruitment of HDAC-1 correlates with deacetylation of histone
H4 on an Rb-E2F target promoter. EMBO Rep 2:794–799
30. Nicolas E, Roumillac C, Trouche D (2003) Balance between
acetylation and methylation of histone H3 lysine 9 on the E2F-
responsive dihydrofolate reductase promoter. Mol Cell Biol
23:1614–1622
31. Morris EJ, Dyson NJ (2001) Retinoblastoma protein partners.
Adv Cancer Res 82:1–54
32. Fanciulli M (2006) Rb and tumorigenesis. Landes Bioscience/
Eureka.com, Springer, Georgetown, New York
33. Park IK, Morrison SJ, Clarke MF (2004) Bmi1, stem cells, and
senescence regulation. J Clin Invest 113:175–179
34. Kirmizis A, Bartley SM, Farnham PJ (2003) Identiﬁcation of the
polycomb group protein SU(Z)12 as a potential molecular target
for human cancer therapy. Mol Cancer Ther 2:113–121
35. Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin
H, Trogani N, Xu H, Cohen D (1999) Histone deacetylase inhi-
bition selectively alters the activity and expression of cell cycle
proteins leading to speciﬁc chromatin acetylation and antiprolif-
erative effects. J Biol Chem 274:34940–34947
36. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC
(1996) Involvement of the cyclin-dependent kinase inhibitor
p16
INK4a in replicative senescence of normal human ﬁbroblasts.
Proc Natl Acad Sci USA 93:13742–13747
37. Maurelli R, Zambruno G, Guerra L, Abbruzzese C, Dimri G,
Gellini M, Bondanza S, Dellambra E (2006) Inactivation of
p16
INK4a (inhibitor of cyclin-dependent kinase 4A) immortalizes
primary human keratinocytes by maintaining cells in the stem cell
compartment. Faseb J 20:1516–1518
38. Trosko JE (2003) Human stem cells as targets for the aging and
diseases of aging processes. Med Hypotheses 60:439–447
39. Ocker M, Schneider-Stock R (2007) Histone deacetylase inhibi-
tors: signalling towards p21
cip1/waf1. Int J Biochem Cell Biol
39:1367–1374
1176 J.-W. Jung et al.